Familial Hemiplegic Migraine with Severe Attacks: A New Report with ATP1A2 Mutation
E Martínez1, R Moreno2, L López-Mesonero1
1Neurology Department, Hospital Clínico Universitario, Valladolid, Spain.
Abstract:
Introduction. Familial hemiplegic migraine (FHM) is a rare disorder characterized by migraine attacks with motor weakness during the aura phase. Mutations in CACNA1A, ATP1A2, SCN1A, and PRRT2 genes have been described. Methods. To describe a mutation in ATP1A2 gene in a FHM case with especially severe and prolonged symptomatology. Results. 22-year-old woman was admitted due to migraine-type headache and sudden onset of right-sided weakness and aphasia; she had similar episodes in her childhood. Her mother was diagnosed with hemiplegic migraine without genetic confirmation. She presented with fever, decreased consciousness, left gaze preference, mixed aphasia, right facial palsy, right hemiplegia, and left crural paresis. Computed tomography (CT) showed no lesion and CT perfusion study evidenced oligohemia in left hemisphere. A normal brain magnetic resonance (MR) was obtained. Impaired consciousness and dysphasia began to improve three days after admission and mild dysphasia and right hemiparesis lasted for 10 days. No recurrences were reported during a follow-up of two years. We identified a variant in heterozygous state in ATP1A2 gene (p.Thr364Met), pathogenic according to different prediction algorithms (SIFT, PolyPhen2, MutationTaster, and Condel). Conclusion. Prolonged and severe attacks with diffuse hypoperfusion in a FHM seemed to be specially related to ATP1A2 mutations, and p.T364M should be considered.
Insights
This study identifies a novel ATP1A2 gene mutation (p.Thr364Met) in a patient with severe familial hemiplegic migraine (FHM). This finding links specific ATP1A2 variants to prolonged FHM attacks and associated brain hypoperfusion.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Familial hemiplegic migraine (FHM) is a rare subtype of migraine with aura, characterized by neurological deficits, particularly motor weakness.
- Genetic mutations in CACNA1A, ATP1A2, SCN1A, and PRRT2 genes are known causes of FHM.
- Understanding the genetic basis of FHM is crucial for diagnosis and potential therapeutic strategies.
Purpose of the Study:
- To investigate a specific mutation in the ATP1A2 gene in a patient presenting with particularly severe and prolonged symptoms of familial hemiplegic migraine.
- To correlate the identified genetic variant with the clinical presentation and neuroimaging findings.
Main Methods:
- Case study of a 22-year-old female with a history of hemiplegic migraine episodes.
- Clinical assessment including neurological examination, fever, decreased consciousness, aphasia, and hemiplegia.
- Neuroimaging techniques including Computed Tomography (CT) and CT perfusion study, alongside Magnetic Resonance (MR) imaging.
- Genetic analysis to identify mutations in the ATP1A2 gene, with pathogenicity prediction using SIFT, PolyPhen2, MutationTaster, and Condel algorithms.
Main Results:
- The patient experienced severe migraine attacks with right-sided weakness, aphasia, decreased consciousness, and hemiplegia, with symptoms lasting up to 10 days.
- CT perfusion revealed oligohemia in the left hemisphere, while initial CT and subsequent MR imaging showed no structural lesions.
- A heterozygous variant in the ATP1A2 gene (p.Thr364Met) was identified and predicted to be pathogenic.
- Symptoms improved within days, with residual mild aphasia and hemiparesis resolving over 10 days, and no recurrence during a two-year follow-up.
Conclusions:
- The ATP1A2 gene mutation p.Thr364Met is associated with severe and prolonged familial hemiplegic migraine attacks.
- Diffuse hypoperfusion observed in FHM may be specifically linked to mutations within the ATP1A2 gene.
- The identified p.T364M variant should be considered in the genetic diagnosis of FHM with severe and prolonged symptomatology.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
ATP Synthase: Mechanism
ATP Synthase: Structure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
ATP Driven Pumps I: An Overview
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
ATP Driven Pumps II: P-type Pumps
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
